FALBERG KATHRYN E
Transactions
50
Companies
15
Filings
11
CIK
0001206977
Recent Transactions
- Award
- Award
- Award
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Sale
- Sale
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Sale
- Award
- Award
- Award
- Award
- Award
- Sale
- Conversion
- Exercise/Conversion
- Sale
- Conversion
- Exercise/Conversion
- Award
- Award
- Gift
- Award
- Award
- Award
- Award
- Disposition to Issuer
- Purchase
- Purchase
- Purchase
- Purchase
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
Companies
15Aimmune Therapeutics, Inc.
Director
- $RCUS
Arcus Biosciences, Inc.
Director
- $ATYR
aTYR PHARMA INC
Director
- $BMRN
BIOMARIN PHARMACEUTICAL INC
Director
- $HALO
HALOZYME THERAPEUTICS, INC.
Director
HUMAN GENOME SCIENCES INC
Director
- $JAZZ
Jazz Pharmaceuticals plc
SVP and CFO
MEDIVATION, INC.
Director
NOVELION THERAPEUTICS INC.
Director
- $NUVB
Nuvation Bio Inc.
Director
- $ORKA
Oruka Therapeutics, Inc.
CFO and COO
Sio Gene Therapies Inc.
Director
- $TTD
Trade Desk, Inc.
Director
Tricida, Inc.
Director
- $URGN
UroGen Pharma Ltd.
Director
Recent Filings
11- 4
FALBERG KATHRYN E
Jun 12, 2026
- 4
FALBERG KATHRYN E
May 26, 2026
- 4
FALBERG KATHRYN E
Mar 25, 2026
- 4
FALBERG KATHRYN E
Mar 9, 2026
- 4
FALBERG KATHRYN E
Jun 12, 2025
- 4
FALBERG KATHRYN E
May 29, 2025
- 4
FALBERG KATHRYN E
May 23, 2025
- 4
FALBERG KATHRYN E
Apr 17, 2025
- 4
FALBERG KATHRYN E
Sep 5, 2024
- 4
FALBERG KATHRYN E
Aug 15, 2024
- 4
FALBERG KATHRYN E
Jun 7, 2024
Address
C/O ARCUS BIOSCIENCES, INC. 3928 POINT EDEN WAY
HAYWARD, CA, 94545